Evidence map›Paper›PMID 34988848›Full record

ArticleSleep & breathing = Schlaf & Atmung2022

Inflammation markers in moderate and severe obstructive sleep apnea: the influence of sex.

Chiara Rocchi, Conti Valentina, Viviana Totaro, Serena Broggi, Simona Lattanzi, Giovanna Viticchi, Lorenzo Falsetti, Mauro Silvestrini, Laura Buratti

Abstract read
PubMed Publisher
In one paragraph

Article in Sleep & breathing = Schlaf & Atmung, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Chiara RocchiNeurological Clinic, Marche Polytechnic University, Via Conca 71, Ancona, 60020, Italy. chiararocchi@hotmail.it.ORCID 0000-0002-1215-9583
Conti ValentinaDepartment of Respiratory Medicine, San Marino Hospital, San Marino, San Marino.
Viviana TotaroNeurological Clinic, Ospedali Riuniti Ancona, Ancona, Italy.
Serena BroggiNeurological Clinic, Marche Polytechnic University, Via Conca 71, Ancona, 60020, Italy.
Simona LattanziNeurological Clinic, Marche Polytechnic University, Via Conca 71, Ancona, 60020, Italy.
Giovanna ViticchiNeurological Clinic, Ospedali Riuniti Ancona, Ancona, Italy.
Lorenzo FalsettiInternal and Subintensive Medicine, Ospedali Riuniti Ancona, Ancona, Italy.
Mauro SilvestriniNeurological Clinic, Marche Polytechnic University, Via Conca 71, Ancona, 60020, Italy.
Laura BurattiNeurological Clinic, Marche Polytechnic University, Via Conca 71, Ancona, 60020, Italy.
Marche Polytechnic University · ITOspedali Riuniti di Ancona · ITUniversity of the Republic of San Marino · SM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeObstructive sleep apnea (OSA) is the most prevalent sleep-related breathing disorder, with a negative impact on cardiovascular health. Different OSA symptoms and treatment response in males and females have been reported. The aim of this study was to investigate inflammatory markers in patients with OSA and the relationship of those markers to disease severity in male and female subjects.

methodsWe considered consecutive subjects referred to the outpatient Sleep Disorder Service of the Respiratory Medicine Department, San Marino Hospital. We included patients with a diagnosis of moderate or severe OSAS and an age range of 45-80 years. Concomitant inflammatory conditions were an exclusion criterion. A polygraphic study and a blood draw for inflammatory markers were performed for each subject.

resultsOf 110 subjects, 59 were males. Severe OSA affected 72 subjects. We analyzed data through a 4-level categorical variable according to sex and OSA severity (moderate OSA, males; severe OSA, males; moderate OSA, females; severe OSA, females), which showed significant differences for interleukin-6 (IL-6) and C-reactive protein (CRP) levels. A significant difference in IL-6 levels with a significant ascending trend (p = 0.045) from females with moderate OSAS to males with severe OSAS emerged in our pairwise comparison for estimated marginal means. Also, a significant trend (p = 0.0001) for CRP levels from males with moderate OSAS to females with severe OSAS was shown.

conclusionsOSA and inflammation are interconnected, and both are associated with vascular diseases. Sex-related differences in OSA phenotypes may help the clinicians aim for a more personalized approach.

Indexed as

Interleukin-6Sleep Apnea, ObstructiveBiomarkersFemaleHumansInflammationMaleSleepBiomarkersInterleukin-6CRPIL-6InflammationOSASex

Identifiers

PMID34988848
OpenAlexW4206543559

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.